Saol Therapeutics Announces Strategic Investment of Up to $115 Million from Oaktree to Support Launch Preparation for SL1009
Why this matters
Capital markets activity continues to be defined by the rotation from bank balance sheets to non-bank lenders. Private credit funds have raised record dry powder; banks have tightened CRE underwriting standards for the sixth consecutive quarter. The result is a market where well-sponsored deals clear, and marginal credit pays a meaningful spread to do so. For LPs, the allocation conversation has shifted decisively toward real estate debt, with equity allocations being deployed more selectively into operator-led platforms.
Editorial analysis · Real Estate Trail Editorial
On the RET wire
- Disclosed capital deal value tracked in September 2026: $23.5B across 49 reported transactions.
- 4 stories mentioning Oaktree on the wire in the past 90 days. Oaktree coverage →
Computed from Real Estate Trail’s own tracked coverage
Financing will fund launch readiness for SL1009 and support lifecycle expansion into Congenital Lactic Acidosis and additional pain indications for SL1002 ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, Sept. 15, 2026…
External link. Real Estate Trail does not republish source content.
Related coverage — Capital
A path to sub-7% mortgage rates is back on the table
As rates have fallen, housing demand has stabilized the last two weeks
Taiwan Semiconductor Manufacturing (TSM) Draws New Sunbelt Real Estate Fund Around Phoenix Fabs
(CMBS) Movement as an Input in Quant Signal Sets
Exclusive: CrossCountry Mortgage demands payment from former LOs, threatens litigation
Documents obtained by HousingWire point to some $2.3M in refis for two LOs and demand total repayment of more than $17K